ECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logo
  • Home
  • Archives
  • Contact
✕
  • Filter by
  • Categories
  • Tags
  • Authors
  • Show all
  • All
  • Advocacy
  • Anal cancer
  • Artificial intelligence (AI)
  • Bladder cancer
  • Brain cancer
  • Breast cancer
  • Colorectal cancer
  • ComboMATCH
  • Esophagus cancer
  • Gallbladder cancer
  • Head and neck cancer
  • Health equity
  • Immunotherapy
  • In memory
  • Kidney cancer
  • Leukemia
  • Liver cancer
  • Lung cancer
  • Lymphoma
  • Mammography
  • Melanoma
  • Myelodysplastic syndrome
  • Myeloma
  • NCI-MATCH
  • Older adults
  • Pancreatic cancer
  • Pancreatic cysts
  • Patient education
  • Patient navigation
  • Patient-reported outcomes
  • Penis cancer
  • Personalized treatment
  • Policy
  • Precision medicine
  • Prevention
  • Prostate cancer
  • Real-world data/evidence
  • Research results
  • Sarcoma
  • Screening for cancer
  • Side effects
  • Survivorship
  • Targeted therapy
  • Upper tract urothelial cancer
  • Young adults
November 3, 2025
November 3, 2025
Categories
  • Editorials

Beating the odds: Steven Merlin’s journey through pancreatic cancer and clinical trials

An inspiring interview with a 13-year survivor of stage 4 pancreas cancer
Do you like it?
1 Read more
November 3, 2025
Patient and doctor talking over clipboard
November 3, 2025
Categories
  • Ongoing Trials

Ongoing Trials: A closer look at ECOG-ACRIN’s clinical trials for patients with pancreatic conditions

For Pancreatic Cancer Awareness Month, we highlight two actively recruiting clinical trials for patients with pancreatic conditions
Do you like it?
0 Read more
May 19, 2025
Research dictionary entry
May 19, 2025
Categories
  • Trial Results

Top trial results of 2024: A year of major progress in cancer treatment

Seven ground-breaking findings from cancer clinical trials in 2024 by ECOG-ACRIN and PrECOG
Do you like it?
0 Read more
July 2, 2024
Research dictionary entry
July 2, 2024
Categories
  • Trial Results

ECOG-ACRIN research round-up – Summer 2024

Takeaways from ECOG-ACRIN trial results presented at the 2024 American Society of Clinical Oncology Annual Meeting
Do you like it?
0 Read more
March 23, 2023
March 23, 2023
Categories
  • Ongoing Trials

Video: Advocates discuss the EA2185 research study for patients with pancreatic cysts

Watch cancer research advocates Lisa Beckendorf and Steven Merlin discuss the EA2185 study for patients with pancreatic cysts
Do you like it?
0 Read more
June 28, 2022
Research dictionary entry
June 28, 2022
Categories
  • Trial Results

Trial Results: ECOG-ACRIN research round-up – Summer 2022

Summaries of recently reported ECOG-ACRIN research results
Do you like it?
0 Read more
September 20, 2021
Patient and doctor talking over clipboard
September 20, 2021
Categories
  • New Trials

Now Enrolling: The APOLLO clinical trial is studying an additional treatment option after standard therapy for certain patients with pancreatic cancer

This study is for patients with pancreatic cancer that has been surgically removed and has a BRCA1, BRCA2, or PALB2 mutation
Do you like it?
0 Read more

News, editorials, and perspectives for the cancer research advocacy community

✕

Categories

  • Editorials
  • New Trials
  • Ongoing Trials
  • Trial Results

Resources

  • Active ECOG-ACRIN Trials
  • Advocacy Organizations
  • Myths and Facts
STAY UP TO DATE

Subscribe to receive updates from the ECOG-ACRIN advocacy committee.

Select list(s) to subscribe to


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact


Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2026 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc